Proov PdG Test Strips: The First FDA-Cleared At-Home Ovulation Confirmation Test

Predicting ovulation has been possible at home for decades. Confirming it actually happened is a fundamentally different, and arguably more important, clinical question.

Presented By Our Partners

Every ovulation predictor kit on the market answers the same question: is your LH surging? But the surge itself is not the endpoint. Ovulation must follow, and after ovulation, progesterone must rise and sustain for approximately 10 to 14 days to support potential implantation and early pregnancy. An estimated 3% to 10% of women experiencing infertility have luteal phase deficiency, where ovulation occurs but progesterone production is inadequate. Standard LH tests cannot detect this condition because they stop measuring at exactly the moment the most clinically important phase begins. A 2024 systematic review published in the Journal of Medical Internet Research by Lyzwinski et al. confirmed that emerging at-home reproductive technologies are moving beyond simple ovulation prediction toward comprehensive cycle phase differentiation, with progesterone confirmation emerging as a critical capability gap that consumer devices are only now beginning to fill.

Proov PdG Test Strips are the first FDA-cleared at-home test designed specifically to confirm successful ovulation by measuring pregnanediol glucuronide (PdG), the urinary metabolite of progesterone. Rather than predicting what might happen, Proov tells women what already did.

What Are Proov PdG Test Strips?

Proov PdG Test Strips are FDA-cleared at-home urine test strips that detect PdG, the primary urinary metabolite of progesterone. When progesterone rises after ovulation, PdG levels in urine rise correspondingly approximately 24 to 48 hours later. By testing PdG levels on specific days during the luteal phase (typically days 7 through 10 after a positive LH test), users can confirm whether ovulation occurred and whether progesterone production reached and maintained adequate levels.

The strips are used with the Proov Insight app, which guides testing timing and interprets results using a proprietary PdG confirmation algorithm. The product costs $39.99 to $59.99 per pack, depending on the strip count and whether the pack includes complementary LH strips for a complete predict-and-confirm protocol. There is no hardware device required; the strips are read visually or via the app’s camera-based reader for semi-quantitative interpretation.

Proov’s core innovation is its singular focus on the post-ovulatory phase. While competitors offer multi-hormone panels, Proov concentrates exclusively on the question most other consumer tools ignore: did your body produce enough progesterone after ovulation to support a healthy luteal phase?

The Science Behind Progesterone and Ovulation Confirmation

Progesterone is produced by the corpus luteum, the temporary endocrine structure formed from the follicle after ovulation releases an egg. Adequate progesterone is essential for endometrial receptivity, implantation support, and early pregnancy maintenance. Serum progesterone levels above 3 ng/mL confirm ovulation occurred, while levels above 10 ng/mL during the mid-luteal phase are generally associated with adequate luteal function.

The clinical significance of post-ovulatory progesterone monitoring is well established. The American Society for Reproductive Medicine recognizes mid-luteal serum progesterone measurement as a standard component of infertility evaluation. However, serum testing captures only a single time point, typically requiring a blood draw on cycle day 21, which assumes a textbook 28-day cycle with ovulation on day 14. For women with irregular cycles, this timing assumption can produce misleading results.

Urinary PdG testing offers an advantage: it can be performed daily at home, capturing the trajectory of progesterone production rather than a single snapshot. A 2023 study published in Scientific Reports by Pattnaik et al. validated quantitative urinary hormone monitoring across 100 women and found that PdG measurements correlated strongly with laboratory ELISA, with a coefficient of variation of approximately 5%. The study demonstrated that multi-day PdG patterns could distinguish ovulatory from anovulatory cycles with 100% specificity.

A 2022 prospective study published in Reproductive Biology and Endocrinology by Yu et al. demonstrated that physiological signals combined with machine learning could predict the fertile window with 87.46% accuracy, but noted that accuracy dropped substantially for irregular menstruators. This finding underscores the value of direct hormone measurement: while physiological proxies like temperature and heart rate can estimate ovulation timing, only progesterone metabolite measurement can confirm that ovulation produced adequate hormonal output.

The broader endocrinology literature establishes that luteal phase deficiency is associated not only with infertility but with recurrent pregnancy loss. Women whose progesterone fails to rise adequately or drops prematurely may experience biochemical pregnancies or early miscarriages that are never explained by conventional testing. Serial PdG monitoring during the luteal phase provides data that a single serum draw on an estimated day 21 cannot capture.

What Proov PdG Test Strips Do Well

Proov’s greatest strength is its clarity of purpose. Rather than attempting to be a comprehensive cycle tracking platform, it answers one critical question with validated accuracy: did ovulation succeed? This focused approach means there is no learning curve around multi-hormone interpretation, no confusion about which wand to use, and no ambiguity about what a positive or negative result means.

Featured Partner

Invest in the Infrastructure Behind Modern Medicine

As healthcare expands beyond hospital walls, the buildings and campuses supporting that shift are generating compelling returns for investors who move early. The Healthcare Real Estate Fund offers qualified investors direct access to a curated portfolio of medical office, outpatient, and specialty care facilities.

Learn More →

The affordability of Proov relative to quantitative hormone monitors is a significant advantage. At $39.99 to $59.99 per pack, a complete luteal phase testing window (4 to 5 tests per cycle) costs a fraction of what multi-hormone monitors charge. For women who already use standard LH strips to predict ovulation and simply want confirmation that it occurred, Proov adds the missing piece without requiring a new hardware investment.

The Proov Insight app provides a Proov Ovulation Confirmation (PdG) score that summarizes whether the luteal phase PdG pattern suggests successful ovulation with adequate progesterone. This scoring system translates raw strip results into an actionable assessment that is easier to interpret than raw hormone concentrations for users without clinical training.

Pricing, Access, and Practical Realities

Proov PdG Test Strips cost $39.99 to $59.99 per pack, with pack sizes varying by product configuration. Some packs include both LH prediction strips and PdG confirmation strips for a complete two-phase protocol. At 4 to 5 PdG strips per cycle, monthly consumable costs range from approximately $15 to $25, making Proov significantly more affordable than multi-hormone monitor systems that cost $50 to $100 per month in consumables.

First-year total cost of ownership is approximately $180 to $300, depending on strip selection and testing frequency. This positions Proov as the most budget-friendly option in the quantitative fertility monitoring category. The product is HSA and FSA eligible.

Proov is FDA cleared specifically as a PdG test, validating its accuracy for detecting the progesterone metabolite in urine. The test is semi-quantitative: the app’s camera reader provides a numerical PdG score, but it is not a fully quantitative assay in the way laboratory immunoassays or devices like Mira and Inito are. Users should understand that Proov confirms whether PdG rose above a threshold associated with successful ovulation, rather than reporting precise progesterone metabolite concentrations.

Who Proov PdG Test Strips Are Best For

Proov is ideal for women trying to conceive who already track ovulation through LH strips or basal body temperature and want to add post-ovulatory confirmation without investing in a multi-hundred-dollar monitoring system. It is particularly valuable for women with a history of unexplained infertility, recurrent early pregnancy loss, or suspected luteal phase deficiency who want actionable data to bring to their clinician.

Women using fertility awareness methods for family planning who want to verify cycle quality beyond LH detection will find Proov’s focused PdG measurement a useful addition to their toolkit. Clinicians who want patients to collect luteal phase data between appointments can recommend Proov as an affordable, accessible self-monitoring tool.

Women who want comprehensive multi-hormone data including estrogen, FSH, and quantitative LH alongside progesterone may find Proov too narrow. The strips measure only PdG and do not provide the full hormonal picture that monitors like Mira or Inito deliver. Users seeking an all-in-one cycle intelligence platform should consider those alternatives.

How Proov PdG Test Strips Compare

The Mira Fertility Monitor ($199 device plus ~$50 to $100/month in wands) and Inito Fertility Monitor ($149 device plus ~$50 to $75/month in strips) both measure PdG alongside LH, E3G, and FSH. These systems provide a more comprehensive hormonal view and fully quantitative results, but at significantly higher cost. Proov’s focused PdG-only approach costs roughly one-fifth as much annually and requires no hardware purchase.

Standard ovulation predictor kits (Clearblue, First Response) at $20 to $50 per cycle detect only the pre-ovulatory LH surge and cannot confirm whether ovulation successfully occurred. Proov fills the gap these products leave, and many users combine LH prediction strips with Proov PdG confirmation strips for a complete predict-and-confirm protocol at a combined cost well below a single multi-hormone monitor.

Wearable cycle trackers like the Oura Ring Gen 3 use temperature and biometric signals to estimate ovulation but cannot directly measure progesterone. The 2025 validation by Thigpen et al. showed the Oura Ring detected 96.4% of ovulations by physiology, but did not assess progesterone adequacy, which is exactly what Proov measures.

Limitations and Open Questions

Proov’s semi-quantitative nature means it provides threshold-based results rather than precise hormone concentrations. Users learn whether PdG rose above a level associated with successful ovulation, but not the exact magnitude of that rise. For women whose clinicians want specific progesterone numbers, a serum blood draw or a fully quantitative monitor may be necessary.

The strips measure only PdG and do not assess estrogen, LH, or FSH. Women with complex cycle irregularities may need a more comprehensive monitoring approach that Proov alone cannot provide. PdG results are most meaningful when paired with prior LH surge detection, meaning Proov works best as a complement to other fertility tracking methods rather than a standalone system.

Urinary PdG levels are influenced by hydration, testing time, and individual metabolic variation. Testing with first morning urine on consistent days during the luteal phase produces the most reliable results. Individual cycles can vary, and a single low PdG result does not necessarily indicate a clinical problem; patterns across multiple cycles are more informative than any individual result.

What This Means for Your Health

Proov PdG Test Strips address what may be the most underserved question in consumer reproductive health: not when will I ovulate, but did ovulation succeed? For women trying to conceive, this distinction can mean the difference between months of unexplained frustration and an actionable data point that directs the next clinical conversation.

Within Healthcare Discovery‘s Five Pillars framework, progesterone health connects to every foundational practice. Adequate sleep supports the hypothalamic-pituitary-ovarian axis that drives progesterone production. Nutritional sufficiency, particularly in vitamin B6, zinc, and healthy fats, supports corpus luteum function. Chronic stress, which elevates cortisol, can suppress progesterone through the “cortisol steal” phenomenon where the body preferentially produces stress hormones at the expense of reproductive hormones. Movement that supports insulin sensitivity helps maintain the metabolic environment necessary for healthy ovarian function.

In the context of the Four Shadows, reproductive hormone health is increasingly recognized as a window into broader metabolic and cardiovascular risk. Women with chronic anovulation or luteal phase deficiency face elevated risks for metabolic dysfunction and cardiovascular disease over the long term. Proov offers an affordable, accessible way to monitor one of the body’s most sensitive indicators of systemic health, turning a $40 pack of test strips into a meaningful early warning system for reproductive and metabolic well-being.

Frequently Asked Questions

What does the Proov PdG test actually measure?
Proov measures pregnanediol glucuronide (PdG), the primary urinary metabolite of progesterone. After ovulation, the corpus luteum produces progesterone, which is metabolized and excreted in urine as PdG. By testing PdG levels on days 7 through 10 after an LH surge, Proov can confirm whether ovulation occurred and whether progesterone production was adequate. It is the first FDA-cleared at-home PdG test.

How much do Proov PdG Test Strips cost?
Proov strips cost $39.99 to $59.99 per pack, depending on configuration. Testing 4 to 5 times per cycle during the luteal phase costs approximately $15 to $25 per month. Annual cost is roughly $180 to $300, making Proov the most affordable option in the quantitative fertility monitoring category. The strips are HSA and FSA eligible.

Can Proov replace a progesterone blood test?
Proov provides semi-quantitative PdG data that can indicate whether progesterone rose to levels associated with successful ovulation. However, it does not provide the precise progesterone concentration that a serum blood test delivers. Proov is best used as a screening and monitoring tool; clinicians may still recommend serum progesterone testing for definitive assessment, particularly when making treatment decisions.

When should I use Proov PdG test strips during my cycle?
Proov recommends testing on days 7, 8, 9, and 10 after a positive LH (ovulation predictor) test, using first morning urine. This window corresponds to the mid-luteal phase when progesterone should be at its peak. The Proov Insight app guides timing based on when you logged your LH surge.

Can Proov detect luteal phase deficiency?
Proov can reveal patterns consistent with inadequate post-ovulatory progesterone, which may suggest luteal phase deficiency. If PdG levels fail to rise or drop prematurely during the testing window, this could indicate that the corpus luteum is not producing sufficient progesterone. However, luteal phase deficiency is a clinical diagnosis that should be confirmed by a healthcare provider using serum testing and clinical evaluation.

Free Daily Briefing

The Latest Longevity Science.
Delivered Every Morning.

Join researchers, physicians, and health professionals getting daily breakthroughs in AI-driven medicine, epigenetics, and longevity research.

Support the research that powers this editorial

Subscribe Free

No spam. Unsubscribe anytime. We respect your inbox.